The levels of IgG in patients with dyslipidemia were significantly reduced compared to healthy controls (p < 0.05) (Figure 2N), while there were no significant differences between groups in levels of IgA, IgM, and IgE (p > 0.05) (Figures 2O–2Q). This evidence concerns the gene CD79A and metabolic syndrome.